Study Provides Proof News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The transmembrane protein B7-H4 has emerged as an interesting therapeutic target in multiple solid tumors, with investigators mostly focusing on the development of antibody-drug conjugates aimed at the pathway.

United statesSouth koreaJosephr podojilAmerican association for cancer researchAmerican society of clinical oncology annual meetingEuropean society for medical oncology congressNorthwestern university feinberg school of medicineNorthwestern university feinberg schoolStudy provides proofCancer researchAnnual meetingMedical oncology congressClinical trials lookAdvance newClinical oncology annual meetingB7 h4